Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled time : 14:15 save search
Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular Point-of-Care Test to Detect SARS-CoV-2
Published: 2021-11-08 (Crawled : 14:15) - biospace.com/
TLIS | $9.0 1.9K
|
|
| O: 9.85%
H: 11.24%
C: 6.38%
covid fda test molecular granted merge sars-cov-2 emergency use authorization
Amneal Launches Generic Dexamethasone Following ANDA Approval by FDA
Published: 2021-10-27 (Crawled : 14:15) - biospace.com/
AMRX | $5.4 0.75% 300K
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: -2.91%
fda approval
BioVie Announces FDA Authorization to Initiate Phase 2 Trials Assessing NE3107’s Pro-motoric Activity in Parkinson’s Disease
Published: 2021-10-26 (Crawled : 14:15) - biospace.com/
BIVI | News | $0.4931 0.96% 330K
|
Health Technology
|
| O: 6.04%
H: 0.0%
C: 0.0%
disease fda phase 2 parkinson trials trial
Sorrento Receives FDA Clearance to Proceed With Clinical Trial for Anti-TROP-2 Antibody Drug Conjugate (TROP-2 ADC) for multiple solid tumors
Published: 2021-10-13 (Crawled : 14:15) - globenewswire.com
SRNE | $0.024 57K
|
Health Technology
|
| O: 2.45%
H: 0.52%
C: -0.15%
fda clearance fda solid tumors antibody drug trial clearance
Zosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Pharmacokinetic Study Results
Published: 2021-10-04 (Crawled : 14:15) - biospace.com/
ZSAN | $0.5576 7.23% -5.85%
|
Health Technology
|
| O: 2.72%
H: 0.67%
C: -5.01%
fda results granted submission topline grant resubmission
Virpax® Pharmaceuticals Receives FDA Response and Guidance on MMS019
Published: 2021-08-17 (Crawled : 14:15) - biospace.com/
VRPX | $3.86 -4.46% 5.1K
|
|
| O: 57.38%
H: 149.32%
C: 132.22%
fda fda response response
Cullinan Oncology Receives FDA Clearance of Investigational New Drug (IND) Application for CLN-619, a Novel MICA/B-targeted Antibody for the Treatment of Solid Tumors
Published: 2021-06-29 (Crawled : 14:15) - biospace.com/
CGEM | $17.06 -5.54% 150K
|
|
| O: -0.42%
H: 4.09%
C: -0.15%
new drug fda clearance treatment fda solid tumors antibody drug clearance
FDA Accepts Amgen's Supplemental New Drug Application For Otezla® (apremilast) For Adults With Mild-To-Moderate Plaque Psoriasis
Published: 2021-05-05 (Crawled : 14:15) - biospace.com/
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -0.5%
H: 3.2%
C: -1.07%
AMGN | $266.895 1.58% 950K
|
Health Technology
|
| O: -0.43%
H: 1.5%
C: 1.24%
new drug fda drug psoriasis fda acceptance application plague
Sol-Gel Technologies Provides Update on FDA Review of EPSOLAY®
Published: 2021-04-27 (Crawled : 14:15) - globenewswire.com
SLGL | $0.9001 11K
|
Health Technology
|
| O: -10.19%
H: 7.21%
C: -2.76%
fda technology
FibroGen Receives Rare Pediatric Disease Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy
Published: 2021-04-15 (Crawled : 14:15) - biospace.com/
FGEN | $1.075 -8.12% 650K
|
Health Technology
|
| O: 0.52%
H: 3.25%
C: -0.31%
disease treatment fda rare pediatric disease designation duchenne designation rare
Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate; Proposed Legislation Would Be Game-Changing for 22nd Century
Published: 2021-04-01 (Crawled : 14:15) - globenewswire.com
XXII 4 | $1.68 -1.75% 190K
|
Health Technology
|
| O: 3.34%
H: 6.62%
C: 2.35%
fda
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
BSFC | $0.0822 27.64% 75M
|
Manufacturing
RWOD | $10.08 26.05% 5.6M
|
n/a
CHRO | $1.53 24.9% 100K
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.